Uzbekistan Ministry of Health taps Agfa for DR project

| | Health Imaging | Screening

Agfa HealthCare has secured a project of 115 CR 30-X CR systems with Drystar 5300 direct digital imagers in Uzbekistan.

Agfa’s CR 30-X is a tabletop CR digitizer that provides integration from x-ray exposure to print or softcopy. It includes Agfa HealthCare's Musica2 image processing software and the NX workstation. Musica2 analyzes images and applies image enhancement parameters, while the NX workstation manages acquisition and workflow. The project also includes tabletop Drystar 5300 direct digital imagers.

The tender for the Ministry of Health is financed by the World Bank. Agfa received the official tender award in July, and final contract approval in early November.

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.